292 related articles for article (PubMed ID: 31575499)
1. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
Miyazaki T; Yanagihara K; Kakeya H; Izumikawa K; Mukae H; Shindo Y; Yamamoto Y; Tateda K; Tomono K; Ishida T; Hasegawa Y; Niki Y; Watanabe A; Soma K; Kohno S
J Infect Chemother; 2020 Feb; 26(2):242-251. PubMed ID: 31575499
[TBL] [Abstract][Full Text] [Related]
2. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
[TBL] [Abstract][Full Text] [Related]
3. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
[TBL] [Abstract][Full Text] [Related]
4. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
[TBL] [Abstract][Full Text] [Related]
5. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
[TBL] [Abstract][Full Text] [Related]
6. Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Caffrey AR; Morrill HJ; Puzniak LA; LaPlante KL
Clin Ther; 2014 Apr; 36(4):552-9. PubMed ID: 24631473
[TBL] [Abstract][Full Text] [Related]
7. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin.
Equils O; da Costa C; Wible M; Lipsky BA
BMC Infect Dis; 2016 Sep; 16(1):476. PubMed ID: 27600290
[TBL] [Abstract][Full Text] [Related]
8. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
[TBL] [Abstract][Full Text] [Related]
9. A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus.
Wang M; Liu X; Tian Z
Trop Med Int Health; 2023 Apr; 28(4):315-323. PubMed ID: 36852899
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.
Rello J; Nieto M; Solé-Violán J; Wan Y; Gao X; Solem CT; De Salas-Cansado M; Mesa F; Charbonneau C; Chastre J
Med Intensiva; 2016 Nov; 40(8):474-482. PubMed ID: 27061776
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.
Tong MC; Wisniewski CS; Wolf B; Bosso JA
Pharmacotherapy; 2016 Jul; 36(7):731-9. PubMed ID: 27208687
[TBL] [Abstract][Full Text] [Related]
12. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study.
Watanabe A; Goto H; Soma K; Kikuchi T; Gomi K; Miki H; Maemondo M; Ikeda H; Kuroki J; Wada H; Yokoyama T; Izumi S; Mitsutake K; Ueda Y
J Infect Chemother; 2012 Apr; 18(2):160-8. PubMed ID: 22041987
[TBL] [Abstract][Full Text] [Related]
15. Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.
Collins CD; Schwemm AK
Value Health; 2015 Jul; 18(5):614-21. PubMed ID: 26297089
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
De Cock E; Krueger WA; Sorensen S; Baker T; Hardewig J; Duttagupta S; Müller E; Piecyk A; Reisinger E; Resch A
Infection; 2009 Apr; 37(2):123-32. PubMed ID: 19277465
[TBL] [Abstract][Full Text] [Related]
17. The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Chavanet P
Med Mal Infect; 2013 Dec; 43(11-12):451-5. PubMed ID: 24238896
[TBL] [Abstract][Full Text] [Related]
18. Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan.
Lin PC; Wang BC; Kim R; Magyar A; Lai CC; Yang YW; Huang YC
J Microbiol Immunol Infect; 2016 Feb; 49(1):46-51. PubMed ID: 26454421
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Alaniz C; Pogue JM
Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
Liu P; Capitano B; Stein A; El-Solh AA
BMC Nephrol; 2017 May; 18(1):168. PubMed ID: 28532398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
